articles Background prostasin, a serine protease, is suggested to be a novel mechanism regulating the epithelial sodium channel (eNaC) expressed in the distal nephron. this study aimed to evaluate whether the human prostasin gene is a novel candidate gene underlying blood pressure (bp) elevation.
Methods
In a sample of healthy African-American (AA) and european-American (eA) twin subjects aged 17.6 ± 3.3 years (n = 920, 45% AAs), racespecific tagging single-nucleotide polymorphisms (tsNps) were identified to tag all the available sNps ± 2 kb up-and downstream of the prostasin gene from Hapmap at r 2 of 0.8-1.0. selection yielded four tsNps in AAs and one in eAs, with one tsNp (rs12597511: C to t) present in both AAs and eAs. results For rs12597511, Ct and tt genotypes exhibited higher systolic bp (sbp) than CC genotype (115.9 ± 1.1 mm Hg vs. 113.7 ± 0.6 mm Hg, P = 0.025 (AAs); and 110.7 ± 0.5 mm Hg vs. 109.6 ± 0.6 mm Hg, P = 0.115 (eAs)). Ct and tt genotypes compared with CC genotype showed a significant increase in diastolic bp (Dbp) in both racial groups (62.5 ± 0.7 mm Hg vs. 60.4 ± 0.4 mm Hg, P = 0.003 (AAs); and 58.2 ± 0.3 mm Hg vs. 56.7 ± 0.4 mm Hg, P = 0.007 (eAs)). Furthermore, there was an increase in radial pulse wave velocity (pWV) in subjects with Ct and tt genotype as compared with those with CC genotype (6.5 ± 0.1 vs. 6.1 ± 0.1 m/s, P < 0.0001) (eAs); and 6.7 ± 0.1 vs. 6.6 ± 0.1 m/s, P = 0.354 (AAs)). Analyses combining AAs and eAs consistently demonstrated a statistical significance of rs12597511 on all the phenotypes including sbp/ Dbp and pWV.
The epithelial sodium channel (ENaC) consisting of α-, β-, and γ-subunits is expressed in the renal distal tubules and constitutes the rate-limiting step for sodium reabsorption. 1 Two monogenic disorders, Liddle's syndrome (salt-retaining hypertension) and pseudohypoaldosteronism type 1 (salt-wasting hypotension) highlight the significance of genetic defects of ENaC in sodium homeostasis and blood pressure (BP) regulation. 1 Furthermore, genetic variants of α-ENaC, β-ENaC, and γ-ENaC were found to be associated with population BP variation or the presence of essential hypertension in some populations, although not in others. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] ENaC activity is tightly regulated by a network of accessory regulatory proteins. In particular, two regulatory proteins have gained great interest: neural precursor cell-expressed developmentally downregulated 4 (Nedd4L) and serum glucocorticoid-inducible kinase (SGK-1). 1 Nedd4L, an ubiquitin ligase, ubiquitinates ENaC to tag the channel for degradation, leading to its removal from the cell membrane. SGK-1, an aldosterone-dependent positive regulator, inhibits the capacity of Nedd4L to downregulate ENaC through phosphorylation. Previously, chromosomal regions harbouring Nedd4L or SGK-1 genes were linked to BP phenotypes, and genetic variants of Nedd4L and SGK-1 genes have been recently associated with BP and hypertension. [13] [14] [15] [16] [17] For example, a significant association between several Nedd4L polymorphisms and hypertension was observed in three populations with essential hypertension including African Americans (AAs) and European Americans (EAs). 16 SGK-1 polymorphisms, alone or synergistically, were associated with cross-sectional and longitudinal BP in over 4,000 EA subjects. 14 Studies in the late 1990s suggested a novel ENaC regulatory mechanism by a glycosylphosphatidylinositol-anchored serine protease expressed in the distal nephron called prostasin. 18, 19 The expression of prostasin was enhanced by aldosterone both in vitro and in vivo, which increases sodium reabsorption in the distal nephron through ENaC. 20 Further, prostasin was articles PRSS8 Gene, blood pressure and Arterial stiffness believed to induct cleavage of γ-ENaC to fully activate the channel. 21 Adenovirus-mediated human prostasin gene delivery caused a marked increase in BP and electrolyte imbalance, which was accompanied by increased plasma aldosterone level and reduced plasma renin activity in rats. 22 These data suggest that prostasin participates in BP and electrolyte homeostasis by interacting with the renin-angiotensin-aldosterone system. Data on humans, however, are scant. 20, 23 In three patients with primary aldosteronism, urinary excretion of prostasin was abnormally elevated and normalized after adrenalectomy. After adrenalectomy, reduction in the urinary excretion of prostasin in these patients was correlated with the increase in the urinary Na + /K + ratio. 20 By conducting spironolactone or saline/Florinef suppression tests in eight patients with raised aldosterone to renin ratio in comparison with 10 healthy volunteers, Olivieri et al. 23 suggested that urinary prostasin may be a candidate marker of ENaC activation in humans. These findings encouraged us to hypothesize that the human prostasin gene denoted as PRSS8 (chromosome 16p11.2) 24 is a novel candidate gene of the ENaC complex underlying the variation of BP in the general population, and thus, the development of essential hypertension.
This study attempted to evaluate the association between genetic variants in the prostasin gene and BP phenotypes in a large sample of normotensive youth including AAs and EAs from the Georgia Cardiovascular Twin Study. Means and ranges of quantitative phenotypes in twins, including cardiovascular traits, have shown to be similar to age-matched individuals from the general population. 25, 26 As illustrated in numerous gene association studies, twins can be efficiently used to study specific candidate genes underlying complex traits such as BP and related phenotypes.
Study population. A total of 920 AA and EA twins (mean age: 17.6 ± 3.3 years; 45% AAs) from the Georgia Cardiovascular Twin Study participated in this study. These included monozygotic (50%) and dizygotic (50%) pairs of same as well as opposite gender. Recruitment and ethnic classification have been described previously. 27 All participants were apparently healthy based on (parental) report of the child's medical history. All subjects in the Georgia Cardiovascular Twin Study were recruited from within a 120-mile radius of the study location, Augusta, Georgia. African and European ancestry were strictly defined for each group. Subjects were classified as AA if (i) both parents reported being of African heritage; (ii) they and the child were born and raised in the United States; and (iii) parents considered themselves and their child to be AA. Subjects were classified as EA if: (i) both parents reported that they were of European ancestry; (ii) they and the child were born and raised in the United States; and (iii) they considered themselves and their child to be EA and not of Hispanic, Native American, or Asian descent. The study was approved by the institutional review board at the Medical College of Georgia and all subjects (and parents if subjects were <18 years) provided written informed consent. The subject characteristics by race and gender are shown in Table 1 .
Measures. After arrival in the laboratory, participants were engaged in a standard battery of anthropometric evaluations using established protocols. 28 Systolic (SBP) and diastolic BP (DBP) measurements (Dinamap 1846 SX; Criticon, Tampa, FL) were taken at 11, 13, and 15 min, during a 15-min relaxation period in which subjects were instructed to relax as completely as possible while laying (supine) on a hospital bed. The average of the last two measurements was used to represent SBP and DBP at rest. Pulse pressure (PP) was calculated as the difference between SBP and DBP. Aorto-radial pulse wave velocity (PWV) was measured noninvasively with applanation tonometry (Millar Instruments, Houston, TX) 29 and analysis software (SphygmoCor, AtCor Medical, Sydney, Australia). Pressure waves were recorded at the common carotid and radial arteries. PWV was then automatically calculated from measurements of pulse transit time and the distance traveled by the pulse between the two recording sites: PWV = distance (meters)/transit time (seconds). (Figure 1) . 24 As such, genotypes of 90 CEU (white) and YRI (black) parent-offspring trio subjects from the PRSS8 locus including 2.0 kb upstream and 2.0 kb downstream of the gene were downloaded from Hapmap phase II database into Haploview. The Tagger algorithm (http://www. broad.mit.edu/hapview/) was used to select tagging singlenucleotide polymorphisms (tSNPs). In January 2008, the database only contained three SNPs in the CEU population (rs1549293, rs12597511, rs2855475, minor allele frequency between 0.386-0.392). One tSNP (rs12597511) was selected which captures all three common SNPs at r 2 of 0.8. In the YRI population, five SNPs are listed with minor allele frequency between 0.03-0.27. Four tSNPs (rs1259711, rs1549294, rs1549295, and rs2855475) were selected that capture those five SNPs at r 2 ≥ 0.8, using the aggressive multimarker tagging mode. In this approach, a multimarker haplotype is reconstructed from the selected tSNPs, which can act as effective predictor for some ungenotyped SNPs that are not explained by a single tSNP. Including multimarker tests for the SNP selection can reduce the genotyping efforts further than the single marker test only. The tSNPs were genotyped by allelic discrimination Taqman assays (Applied Biosystems, Foster City, CA). PCR were performed in a 96-well format in a total of 5 µl reaction volume using 10 ng of genomic DNA and FAM/VIC dye labeled allelic probes with the Taqman Universal Fast Master mix (Applied Biosystems). The Taqman assay plates were transferred to an ABI 7500 Fast Real Time PCR system in which the fluorescence intensity in each well of the plate was recorded and genotypes were analyzed using Sequence Detection Software 1.3. Genotyping quality control procedures included genotyping 10% duplicates for accuracy checking and inclusion of both positive and nontemplate controls in each 96-well plate.
Analytical approach. Generalized estimating equations 30 were applied to test the association between each individual tSNPs and phenotype in AAs and EAs separately, after the effects of age, gender, and body mass index (BMI) were adjusted. For related individuals, conventional statistical analyses lead to inflated significance. Generalized estimating equation accounts for dependency of the observations within pairs and yields unbiased standard errors and P values. We first modeled the effects of age, gender, and BMI on SBP and DBP, PP, and PWV. After arriving at the most parsimonious full " environmental" model including only significant terms, polymorphisms or haplotypes were then added to test for main effects and interactions. To reduce the numbers of tests, we first performed a two-degree of freedom overall test (codominant models) of genotypic association. Only in the presence of a significant association, one-degree of freedom models including the additive, recessive, and dominant effects were further tested to find the best mode of inheritance. Simultaneously modeling gender as a factor in our model is more powerful than subgroup analyses, and it also allows us to statistically test for gender-specific effects of the polymorphisms and haplotypes. However, AAs and EAs were analyzed separately, because selected tSNPs were race-specific. The haplotype trend regression approach was used to test for associations of statistically inferred haplotypes with the abovementioned phenotypes. 30 Hardy-Weinberg equilibrium and racial differences in allele frequencies were tested by χ 2 -tests in subjects including only one of each twin pair chosen randomly to prevent inflated significance. Single locus association analyses and haplotype trend regression were performed with STATA 8 (StataCorp, College Station, TX).
results study population Table 1 describes the study population. Boys were taller than girls in each racial group. EA participants were slightly older than AA participants. AA girls had greater BMI than AA boys, yet EA boys had greater BMI than EA girls. AAs had higher BMI, SBP, DBP, and radial PWV than EAs. In both AAs and EAs, males had higher SBP, yet lower DBP as compared to females.
allele frequencies
The minor allele frequency of rs12597511 was more common in EAs than AAs, 35% vs. 11% (P < 0.0001). The minor allele frequencies of rs1549294 (C/T) and rs2855475 (C/T) were 10% in AAs and 35% in EAs, respectively. All the tSNPs except rs1549295 (C/T) were in Hardy-Weinberg equilibrium. The rs1549295 SNP in AAs deviated significantly from Hardy-Weinberg equilibrium, possibly due to its low allele frequency (4%).
genotype and phenotype association analyses
None of the interactions between gender and individual tSNPs was significant for all the phenotypes including SBP, DBP, PP, and PWV. A main effect of the T allele of rs12597511 in a dominant mode on the phenotypes was observed in both AAs and EAs ( articles PRSS8 Gene, blood pressure and Arterial stiffness and AAs (P = 0.218). Finally, in EAs, there was an increase in PWV in youths with CT or TT genotype as compared to those with CC genotype (6.6 vs. 6.4 m/s, P < 0.0001), which remained statistically significant even after adjustment of SBP (P < 0.0001), DBP (P = 0.001), and mean arterial pressure (P = 0.001). This remained significant after Bonferroni correction for multiple comparisons. In AAs, there was a nonsignificant increase of PWV in CT and TT genotypes when compared to CC genotype (6.7 ± 0.1 vs. 6.6 ± 0.1 m/s, P = 0.354). The haplotypic analysis findings in AAs with respect to the rs12597511 tSNP were supportive, yet not more informative. The haplotype data thus were not presented. We did not find any association between rs1549294, rs1549295, rs2855475 with any of the phenotypes. For rs12597511that AAs and EAs had in common, we decided to conduct an analysis combining both races and test for potential interaction between race and rs12597511. Thus, all individuals including AAs and EAs were pooled for additional analyses, as we did previously in association studies of biracial cohorts. 30 The main effect of rs12597511 in the dominant mode was consistently observed on all phenotypes, after adjustment of age, gender, race, and BMI. Individuals with CT and TT genotypes (n = 376) compared with those with CC genotype (n = 542) had increased SBP (112.9 ± 0.5 mm Hg vs. 111.4 ± 0.4 mm Hg, P = 0.009) and DBP (60.2 ± 0.3 mm Hg vs. 58.5 ± 0.3 mm Hg, P = 0.001). Similarly, youths with CT and TT genotypes exhibited elevated PP than those with CC genotype (65.2 ± 0.5 vs. 62.9 ± 0.4 mm Hg, P = 0.007). Moreover, there was an increase in radial PWV in youths with CT and TT genotypes as compared with those with CC genotype (6.6 ± 0.1 vs. 6.4 ± 0.1 m/s, P = 0.008). Thus, effects of rs12597511 became clearly significant in this combined analysis for all phenotypes. However, none of the interactions between race and rs12597511 were significant for SBP, DBP, PP, or PWV.
discussion
The human prostasin gene (PRSS8) is located on chromosome 16, 24 where several loci have shown strong or suggestive linkage to BP and related phenotypes by genome-wide linkage scans. [31] [32] [33] [34] It is accepted that a gene-wide examination by a minimal subset of tSNPs can effectively capture information of all common variants and haplotypes by taking into account patterns of linkage disequilibrium across the gene. 35, 36 Our gene-wide analyses using tSNPs disclose the contribution of the genetic variance of human prostasin gene to BP elevation and arterial stiffness in normotensives, and therefore, the potential impact on the future development of hypertension.
The present study demonstrates consistencies for our gene association findings. First, because of the race-specific tSNP selection, genotype and phenotype association analyses were done separately in AAs and EAs. One of the tSNPs, rs12597511, was associated with BP and related phenotypes in both racial groups. Although some of the associations only reached a statistical significance in one of the two racial groups, similar trends were yet seen in both racial groups. The low minor allele frequency in AAs compared to EAs may be one explanation why effects on PP and PWV were not significant in AAs. Of note, when AAs and EAs were combined, the main effect of rs12597511 in the dominant mode was consistently observed and significant for all phenotypes including SBP, DBP, and PWV. Second, a considerable number of SNPs in previously studied candidate genes in the literature are either associated with SBP, or DBP, whereas rs12597511 was found to be associated with both SBP and DBP. The SNP located in intron 2 might not change the expression or activity of prostasin, unless there are some unknown regulatory elements in intron 2. However, it can be in tight linkage disequilibrium with one or more causal variants. The increase in the levels or function of prostasin caused by functional genetic variants might amplify or result in the prostasin-dependent release of an inhibitory peptide from γ-ENaC, subsequently cleaving the channel and causing an increased channel gating or open probability. 21 ENaC activation in the distal nephron augments tubular sodium reabsorption, and extracellular volume expansion, which leads to BP elevation. Third, rs12597511 is associated with increased PWV. Arterial stiffness can be evaluated by measuring PWV between two sites in the arterial tree, with a higher PWV indicating stiffer arteries. 37 There is a clear relationship between PWV and BP. [38] [39] [40] BP elevation is one of the major determinants of arterial stiffness, which is related to a number of molecular changes of the load-bearing media of elastic arteries. [38] [39] [40] Elevated BP in youths carrying the T allele of rs12597511 could result in arterial stiffness and related preclinical cardiovascular disease. On the other hand, after adjustment of SBP, DBP, and mean arterial pressure, the association of rs12597511 with PWV remained significant. It is known that increased PWV is a significant independent predictor of adverse cardiovascular events in hypertensive adults. 39, 40 We thus speculate that genetic variance of the human prostasin gene might be directly involved in arterial stiffness.
The contribution of increased PWV to the pathogenesis of hypertension, cardiovascular damage, and renal dysfunction has stimulated interest in defining the determinants of arterial stiffness. 39, 40 In addition to transmural pressure, structural components within the arterial wall such as collagen, elastin, and cell-matrix interactions are important determinants of arterial stiffness. Furthermore, a degree of functional regulation of smooth muscle tone by circulating and locally generated vasoactive substances may also influence elastic and muscular artery stiffness. 41 ENaC is expressed in endothelial cells and smooth muscle cells. 42, 43 In vascular endothelium, aldosterone induces ENaC expression and insertion into the plasma membrane. Upon functional blockage with amiloride, the ENaC channels disappear from the cell surface and from intracellular pools, indicating either channel degradation and/or membrane pinch-off. 42 Recently, expression of ENaC proteins was found to be involved in normal smooth muscle cell migration, suggesting a potential new role for ENaC proteins in vascular tissue repair. 43 In fact, ENaC has been recognized as a mechanosensor in sensory neurons and vascular smooth muscles and required for vessel responses to pressure in isolated rat arteries. 44, 45 Prostasin is widely distributed in various tissues including the heart and vessel wall. 22, [46] [47] [48] Expression and activity of prostasin determined by gene and environment interaction may affect ENaC activity and subsequently cause pressure-independent and/or pressure-dependent arterial alteration and stiffness. Alternatively, because of the interactions between prostasin and the renin-angiotensin-aldosterone system, prostasin increase could lead to the elevation of levels of aldosterone, 22 which is a major stimulus for arterial fibrosis and collagen accumulation, thus favoring arterial stiffness. 49, 50 There are concerns and limitations in the present study. First, replication in an independent population is requisite for gene association studies for complex diseases such as hypertension. Specially, this is the first gene association study for the prostasin gene. However, as discussed above, the tSNP selection was race-specific, such that race-specific genotypephenotype association analyses were conducted. The positive findings from one racial group were able to be replicated in the other racial group, albeit some of the associations only showed nonsignificance statistically. We call on additional studies to potentially replicate these findings either through crosssectional or longitudinal study design. In particular, studies investigating the association of variation in the human prostasin gene with the presence of essential hypertension in adults are warranted. Second, the functionality of the genetic variants of the human prostasin gene needs to be further elucidated using in vivo and in vitro approaches. For example, the relationships between levels of urinary prostasin and rs12597511 can be examined in vivo. Lastly, although we undertook a gene-wide study design (tSNPs) based on the human HapMap database, the gene coverage is incomplete. Resequencing of the prostasin gene would be more informative.
In summary, this is the first study to investigate the effect of variation in the human prostasin gene on BP and PWV. BP elevation and arterial damage tracks from late childhood into adulthood with a relatively consistent progression. Although the rs12597511 SNP seems to account for only an over 2 mm Hg increase in BP and a lesser difference in PWV, affected young individuals may be prone to the future development of arterial hypertension. Finding causative genes of BP elevation and arterial stiffness in youths is of great significance and will help to identify individuals at risk for cardiovascular disease and events. This study introduces a novel candidate gene for hypertension and arterial stiffness, which would endorse further investigations including longitudinal study design, population with established hypertension, biomarker discovery, functional studies in vivo and in vitro, and potential therapeutic approaches.
